Skip to main content
TSE:NRI

Nuvo Pharmaceuticals Inc. (NRI.TO) News Headlines

C$35.94
+0.82 (+2.34 %)
(As of 05/14/2021 12:00 AM ET)
Add
Compare
Today's Range
C$35.94
C$35.94
50-Day Range
C$0.91
C$36.60
52-Week Range
C$0.43
C$1.20
VolumeN/A
Average Volume19,371 shs
Market CapitalizationC$409.23 million
P/E RatioN/A
Dividend YieldN/A
BetaN/A

Headlines

Nuvo Pharmaceuticals Inc. (NRI.TO) (TSE NRI) News Headlines Today

SourceHeadline
Miravo Healthcare™ to Present at Q2 Virtual Investor SummitMiravo Healthcare™ to Present at Q2 Virtual Investor Summit
markets.businessinsider.com - May 11 at 9:59 AM
Miravo Healthcare™ Announces First Quarter 2021 Results Release Date and Virtual Annual Meeting of ShareholdersMiravo Healthcare™ Announces First Quarter 2021 Results Release Date and Virtual Annual Meeting of Shareholders
markets.businessinsider.com - May 3 at 7:57 AM
Global Over the Counter Drugs Market (2020 to 2025) - by Mode of Intake, Product, End-user and GeographyGlobal Over the Counter Drugs Market (2020 to 2025) - by Mode of Intake, Product, End-user and Geography
benzinga.com - April 30 at 9:54 AM
Miravo Healthcare™ to Present at Upcoming Investor ConferencesMiravo Healthcare™ to Present at Upcoming Investor Conferences
markets.businessinsider.com - April 9 at 8:20 AM
Miravo Healthcare to present at the Q1 Virtual Investor SummitMiravo Healthcare to present at the Q1 Virtual Investor Summit
markets.businessinsider.com - March 11 at 9:48 AM
Earnings Update: Heres Why Analysts Just Lifted Their Nuvo Pharmaceuticals Inc. (TSE:MRV) Price Target To CA$2.60Earnings Update: Here's Why Analysts Just Lifted Their Nuvo Pharmaceuticals Inc. (TSE:MRV) Price Target To CA$2.60
finance.yahoo.com - March 10 at 7:41 AM
Miravo Healthcare™ Files Preliminary Base Shelf ProspectusMiravo Healthcare™ Files Preliminary Base Shelf Prospectus
finance.yahoo.com - March 8 at 5:20 PM
Dr Reddys loses bid to invalidate Horizon arthritis drug patentsDr Reddy's loses bid to invalidate Horizon arthritis drug patents
reuters.com - February 17 at 10:36 PM
Miravo Healthcare™ to Host Investor Webcast on January 28, 2021 at 2:00 p.m. ESTMiravo Healthcare™ to Host Investor Webcast on January 28, 2021 at 2:00 p.m. EST
finance.yahoo.com - January 14 at 7:28 PM
Miravo Healthcare™ Announces the Canadian Commercial Launch of NeoVisc®+ and NeoVisc® ONE for the Treatment of Pain and Improvement of Joint Functionality of the KneeMiravo Healthcare™ Announces the Canadian Commercial Launch of NeoVisc®+ and NeoVisc® ONE for the Treatment of Pain and Improvement of Joint Functionality of the Knee
finance.yahoo.com - January 13 at 8:46 AM
Nuvo Pharmaceuticals® Announces Third Quarter 2020 ResultsNuvo Pharmaceuticals® Announces Third Quarter 2020 Results
finance.yahoo.com - November 16 at 8:33 AM
Nuvo Pharmaceuticals™ Announces Third Quarter 2020 Results Release Date and Conference Call DetailsNuvo Pharmaceuticals™ Announces Third Quarter 2020 Results Release Date and Conference Call Details
finance.yahoo.com - November 2 at 7:33 AM
Nuvo Pharmaceuticals Inc. Regis (23N.SG)Nuvo Pharmaceuticals Inc. Regis (23N.SG)
in.finance.yahoo.com - October 10 at 1:05 PM
Nuvo Pharmaceuticals®  to Webcast Live at Life Sciences Investor Forum September 17thNuvo Pharmaceuticals® to Webcast Live at Life Sciences Investor Forum September 17th
finance.yahoo.com - September 14 at 8:38 AM
Nuvo Pharmaceuticals® Announces Second Quarter 2020 ResultsNuvo Pharmaceuticals® Announces Second Quarter 2020 Results
finance.yahoo.com - August 10 at 8:43 AM
Nuvo Pharmaceuticals® Announces Director Election Results of its Annual & Special Meeting of ShareholdersNuvo Pharmaceuticals® Announces Director Election Results of its Annual & Special Meeting of Shareholders
finance.yahoo.com - May 12 at 4:24 PM
Nuvo Pharmaceuticals® Announces First Quarter 2020 ResultsNuvo Pharmaceuticals® Announces First Quarter 2020 Results
finance.yahoo.com - May 11 at 5:52 PM
C-Suite At The Open: Jesse Ledger, Chief Executive Officer, Nuvo Pharmaceuticals Inc., tells his Companys Story. Filmed on April 24, 2020C-Suite At The Open: Jesse Ledger, Chief Executive Officer, Nuvo Pharmaceuticals Inc., tells his Company's Story. Filmed on April 24, 2020
finance.yahoo.com - April 30 at 3:46 PM
Nuvo Pharmaceuticals™ Announces District Court Decision to Uphold U.S. Pennsaid® 2% PatentNuvo Pharmaceuticals™ Announces District Court Decision to Uphold U.S. Pennsaid® 2% Patent
www.bloomberg.com - April 26 at 12:15 AM
Full interview: Nuvo Pharmaceuticals subsidiary announces Takeda’s Cabpirin approved in JapanFull interview: Nuvo Pharmaceuticals subsidiary announces Takeda’s Cabpirin approved in Japan
www.proactiveinvestors.com - April 1 at 8:53 PM
Nuvo Pharmaceuticals® to Webcast Live at Life Sciences Investor Forum March 26thNuvo Pharmaceuticals® to Webcast Live at Life Sciences Investor Forum March 26th
finance.yahoo.com - March 23 at 8:36 AM
Edited Transcript of NRI.TO earnings conference call or presentation 25-Feb-20 1:30pm GMTEdited Transcript of NRI.TO earnings conference call or presentation 25-Feb-20 1:30pm GMT
finance.yahoo.com - March 9 at 6:50 PM
Nuvo Pharmaceuticals® Announces Health Canada Approves Suvexx™ For The Acute Treatment of MigraineNuvo Pharmaceuticals® Announces Health Canada Approves Suvexx™ For The Acute Treatment of Migraine
finance.yahoo.com - February 27 at 6:48 PM
Nuvo Pharmaceuticals Inc. (NRI.TO)Nuvo Pharmaceuticals Inc. (NRI.TO)
ca.finance.yahoo.com - February 25 at 1:47 PM
Nuvo Pharmaceuticals® Announces 2019 and Fourth Quarter ResultsNuvo Pharmaceuticals® Announces 2019 and Fourth Quarter Results
finance.yahoo.com - February 25 at 8:46 AM
Some Nuvo Pharmaceuticals (TSE:NRI) Shareholders Have Taken A Painful 85% Share Price DropSome Nuvo Pharmaceuticals (TSE:NRI) Shareholders Have Taken A Painful 85% Share Price Drop
finance.yahoo.com - February 18 at 7:53 AM
Nuvo Pharmaceuticals™ Receives Approval from German Regulatory Authorities to Conduct Pennsaid® 2% Phase 3 Trial forNuvo Pharmaceuticals™ Receives Approval from German Regulatory Authorities to Conduct Pennsaid® 2% Phase 3 Trial for
www.bloomberg.com - February 11 at 7:00 PM
Nuvo Pharmaceuticals™ Responds to Market ActivityNuvo Pharmaceuticals™ Responds to Market Activity
finance.yahoo.com - February 11 at 7:00 PM
Nuvo Pharmaceuticals™ Announces Signing of Definitive Agreements to Acquire Commercial Products and Infrastructure from AraleNuvo Pharmaceuticals™ Announces Signing of Definitive Agreements to Acquire Commercial Products and Infrastructure from Arale
www.bloomberg.com - February 10 at 11:25 PM
How Does Nuvo Pharmaceuticals Inc. (TSE:NRI) Affect Your Portfolio Volatility?How Does Nuvo Pharmaceuticals Inc. (TSE:NRI) Affect Your Portfolio Volatility?
finance.yahoo.com - November 19 at 2:08 PM
Nuvo Pharmaceuticals™(Ireland) Limited Enters into Resultz® License and Supply Agreement with Fagron Belgium NV forNuvo Pharmaceuticals™(Ireland) Limited Enters into Resultz® License and Supply Agreement with Fagron Belgium NV for
www.bloomberg.com - November 9 at 11:30 PM
Edited Transcript of NRI.TO earnings conference call or presentation 31-Oct-19 12:30pm GMTEdited Transcript of NRI.TO earnings conference call or presentation 31-Oct-19 12:30pm GMT
finance.yahoo.com - November 3 at 2:14 PM
Stocks in play: Nuvo Pharmaceuticals Inc.Stocks in play: Nuvo Pharmaceuticals Inc.
ca.finance.yahoo.com - November 2 at 6:51 PM
Nuvo Pharmaceuticals™ Announces Third Quarter 2019 Results Release Date and Conference Call DetailsNuvo Pharmaceuticals™ Announces Third Quarter 2019 Results Release Date and Conference Call Details
finance.yahoo.com - October 17 at 8:15 AM
Could The Nuvo Pharmaceuticals Inc. (TSE:NRI) Ownership Structure Tell Us Something Useful?Could The Nuvo Pharmaceuticals Inc. (TSE:NRI) Ownership Structure Tell Us Something Useful?
finance.yahoo.com - September 11 at 8:52 AM
Nuvo Pharmaceuticals™ Update to Nuvos Presentation Time at H.C. Wainwright Global Investment ConferenceNuvo Pharmaceuticals™ Update to Nuvo's Presentation Time at H.C. Wainwright Global Investment Conference
finance.yahoo.com - September 9 at 9:39 AM
Edited Transcript of NRI.TO earnings conference call or presentation 14-Aug-19 12:30pm GMTEdited Transcript of NRI.TO earnings conference call or presentation 14-Aug-19 12:30pm GMT
finance.yahoo.com - September 7 at 2:58 PM
Nuvo Pharmaceuticals™ to Present at H.C. Wainwright Global Investment ConferenceNuvo Pharmaceuticals™ to Present at H.C. Wainwright Global Investment Conference
finance.yahoo.com - September 4 at 10:05 AM
BRIEF-Nuvo Pharmaceuticals Q2 Adjusted Total Revenue $19.1 MillionBRIEF-Nuvo Pharmaceuticals Q2 Adjusted Total Revenue $19.1 Million
www.msn.com - August 15 at 11:30 AM
Nuvo Pharmaceuticals™ Announces 2019 Second Quarter ResultsNuvo Pharmaceuticals™ Announces 2019 Second Quarter Results
finance.yahoo.com - August 14 at 9:04 AM
Nuvo Pharmaceuticals™ Announces Second Quarter 2019 Results Release Date and Conference Call DetailsNuvo Pharmaceuticals™ Announces Second Quarter 2019 Results Release Date and Conference Call Details
finance.yahoo.com - August 12 at 7:05 PM
The Nuvo Pharmaceuticals (TSE:NRI) Share Price Is Down 89% So Some Shareholders Are Rather UpsetThe Nuvo Pharmaceuticals (TSE:NRI) Share Price Is Down 89% So Some Shareholders Are Rather Upset
finance.yahoo.com - July 11 at 6:11 PM
Nuvo Pharmaceuticals™ Announces Director Election Results of its Annual General Meeting and Updates to the Facility Agreement with DeerfieldNuvo Pharmaceuticals™ Announces Director Election Results of its Annual General Meeting and Updates to the Facility Agreement with Deerfield
markets.businessinsider.com - June 26 at 8:41 AM
Nuvo Pharmaceuticals™ Provides Corporate UpdateNuvo Pharmaceuticals™ Provides Corporate Update
finance.yahoo.com - June 17 at 9:00 AM
IIROC Trading Halt - NRIIIROC Trading Halt - NRI
finance.yahoo.com - May 15 at 8:31 PM
Nuvo Pharmaceuticals™ Announces that U.S. Court of Appeals for the Federal Circuit Reverses District Courts Decision Related to Certain Vimovo PatentsNuvo Pharmaceuticals™ Announces that U.S. Court of Appeals for the Federal Circuit Reverses District Court's Decision Related to Certain Vimovo Patents
finance.yahoo.com - May 15 at 8:31 PM
IIROC Trade Resumption - NRIIIROC Trade Resumption - NRI
finance.yahoo.com - May 15 at 8:31 PM
Edited Transcript of NRI.TO earnings conference call or presentation 14-May-19 12:30pm GMTEdited Transcript of NRI.TO earnings conference call or presentation 14-May-19 12:30pm GMT
finance.yahoo.com - May 15 at 8:45 AM
Nuvo Research: 1Q Earnings SnapshotNuvo Research: 1Q Earnings Snapshot
finance.yahoo.com - May 14 at 7:50 PM
Nuvo Pharmaceuticals™ Announces 2019 First Quarter ResultsNuvo Pharmaceuticals™ Announces 2019 First Quarter Results
finance.yahoo.com - May 14 at 8:53 AM
This page was last updated on 5/15/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.